ProgressImage ProgressImage
Bal Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524824 border-img ISIN Demat INE083D01012 border-img Book Value 62.07 border-img NSE Symbol BALPHARMA border-img Div & Yield % 1.46 border-img Market Cap ( Cr.) 130.61 border-img P/E 16.71 border-img EPS 4.91 border-img Face Value 10
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 302.50338.54303.10280.37249.31170.67
Excise Duty 0.000.000.000.000.000.00
Net Sales 302.50338.54303.10280.37249.31170.67
Other Income 2.152.302.196.492.693.63
Stock Adjustments 7.081.0617.904.85-5.13-3.32
Total Income 311.73341.90323.19291.71246.87170.98
EXPENDITURE :       
Raw Materials 164.85192.80187.83171.35145.4581.39
Power & Fuel Cost 8.298.736.875.374.704.68
Employee Cost 61.8359.5751.5644.4639.6248.78
Other Manufacturing Expenses 10.7012.9520.2014.649.127.07
Selling & Administrative Expenses 33.2132.2726.2121.6415.4417.59
Miscellaneous Expenses 0.421.561.904.353.240.82
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 279.30307.89294.56261.82217.57160.34
Operating Profit 32.4234.0128.6229.8929.3010.64
Interest 17.0414.6412.5910.6012.2512.69
Gross Profit 15.3819.3716.0319.2917.05-2.05
Depreciation 9.6510.057.487.247.267.03
Profit Before Tax 5.739.328.5512.059.79-9.08
Tax -0.140.762.035.420.38-0.15
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -1.930.840.39-1.940.32-0.03
Reported Net Profit 7.807.736.138.589.10-8.90
Extraordinary Items 0.000.050.030.780.040.00
Adjusted Net Profit 7.807.686.107.809.06-8.90
Adjustment below Net Profit 0.000.000.000.000.00-0.29
P & L Balance brought forward 42.9036.7442.3735.2726.1836.79
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 1.911.571.561.480.001.42
P & L Balance carried down 48.7942.9046.9442.3735.2726.17
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 12.0012.0010.0010.0010.000.00
Dividend Per Share(Rs) 1.201.201.001.001.000.00
Earnings Per Share-Unit Curr 4.904.893.905.796.14-6.28
Earnings Per Share(Adj)-Unit Curr 4.904.893.905.796.14-6.28
Book Value-Unit Curr 62.0758.7461.2158.2852.8846.53
Book Value(Adj)-Unit Curr 62.0758.7461.2158.2852.8846.53

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
close
refresh